A survey of drug interactions on the patients treated with anti-cancer agents by spontaneous adverse events reporting system in japan

• In: Poster presentation
• At: Seoul (South Korea) (2017)
• Type: Poster
• Poster code: POS-PAA-012
• By: MOMO, Kenji (Teikyo Heisei University, Faculty of Pharmaceutical Sciences, Nakano-ku, Japan)
• Co-author(s): Kenji Momo: Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Japan
  Yuriko Yonaga: Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Japan
  Tatsuya Watanabe: Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Japan
  Masayoshi Koinuma: Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Japan
  Hitoshi Nakamura: Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Japan
  
• Abstract:

  Background

  Clinically relevant interactions between anti-cancer agents and prescribed medicine were estimated approximately 27%. However, the details are not clear.

  Purpose

  The aim of this study was to clarify the cases with drug interactions of anti-cancer agents by spontaneous adverse events reporting system and assess the severity of these

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login